May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis

Medical Oncology

Volumn 28, Issue 1, 2011, Pages 42-50

  Wang, Hai ^a   Guan, Bing ^b   Shi, Qunli ^a,b   Ma, Henhui ^a   Zhou, Hangbo ^a   Wang, Xuan ^a   Zhou, Xiaojun ^a,b  

^a JINLING HOSPITAL   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Basal like carcinoma; Fluorescence in situ hybridization; Immunohistochemistry; Metaplastic breast carcinoma; Ultrastructure

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P63;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL ARTICLE; CYTOPLASM; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; METAPLASIA; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79952247905     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9399-1     Document Type: Article

References (32)

1. I Treilleux B Morellon-Mialhe 2009 Basal-like breast cancer: a review Ann Pathol 29 180 186 19619822 10.1016/j.annpat.2009.04.001
2. TO Nielsen FD Hsu K Jensen M Cheang G Karaca Z Hu T Hernandez-Boussard C Livasy D Cowan L Dressler LA Akslen J Ragaz AM Gown CB Gilks M van de Rijn CM Perou 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374 15328174 10.1158/1078-0432.CCR-04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D (Pubitemid 39100473)
3. EA Rakha ME El-Sayed J Reis-Filho IO Ellis 2009 Patho-biological aspects of basal-like breast cancer Breast Cancer Res Treat 113 411 422 18327637 10.1007/s10549-008-9952-1
4. C Sotiriou SY Neo LM McShane EL Korn PM Long A Jazaeri P Martiat SB Fox AL Harris ET Liu 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 10393 10398 12917485 10.1073/pnas.1732912100 1:CAS:528:DC%2BD3sXntFynsrk%3D (Pubitemid 37071889)
5. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel S Deng H Johnsen R Pesich S Geisler J Demeter CM Perou PE Lonning PO Brown AL Borresen-Dale D Botstein 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 12829800 10.1073/pnas.0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D (Pubitemid 36842560)
6. GM Tse PH Tan TC Putti PC Lui B Chaiwun BK Law 2006 Metaplastic carcinoma of the breast: a clinicopathological review J Clin Pathol 59 1079 1083 16467167 10.1136/jcp.2005.030536 1:CAS:528:DC%2BD28Xht1SgtrfK (Pubitemid 44570331)
7. I Natsiopoulos A Chatzichristou I Stratis A Skordalaki N Makrantonakis 2007 Metaplastic breast carcinoma in a patient with Von Recklinghausen's disease Clin Breast Cancer 7 573 575 17509168 10.3816/CBC.2007.n.015 (Pubitemid 46725252)
8. PC Lui GM Tse PH Tan G Jayaram TC Putti B Chaiwun NH Chan PP Lau KL Mak AT Khin 2007 Fine-needle aspiration cytology of metaplastic carcinoma of the breast J Clin Pathol 60 529 533 16798932 10.1136/jcp.2006.039412 (Pubitemid 46867164)
9. S Leibl M Gogg-Kammerer A Sommersacher H Denk F Moinfar 2005 Metaplastic breast carcinomas: are they of myoepithelial differentiation? Immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers Am J Surg Pathol 29 347 353 15725803 10.1097/01.pas.0000152133.60278.d2 (Pubitemid 40321970)
10. F Penault-Llorca F Mishellany 2009 Case 7: spindle cell carcinoma of the breast or metaplastic carcinoma Ann Pathol 29 223 227 19619830 10.1016/j.annpat.2009.02.013
11. P Robbins S Pinder N de Klerk H Dawkins J Harvey G Sterrett I Ellis C Elston 1995 Histological grading of breast carcinomas: a study of interobserver agreement Hum Pathol 26 873 879 7635449 10.1016/0046-8177(95)90010-1 1:STN:280:DyaK2Mzmt1ahtA%3D%3D
12. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403 410 1757079 10.1111/j.1365-2559.1991.tb00229.x 1:STN:280:DyaK38%2FpvVSltw%3D%3D
13. N Kuroda M Ohara K Inoue K Mizuno N Fujishima N Hamaguchi GH Lee 2009 The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma Med Mol Morphol 42 128 131 19536621 10.1007/s00795-008-0428-5 1:CAS:528:DC%2BD1MXntlOgsbo%3D
14. E Rakha JS Reis-Filho 2009 Basal-like breast carcinoma: from expression profiling to routine practice Arch Pathol Lab Med 133 860 868 19492878
15. EA Rakha JS Reis-Filho IO Ellis 2008 Basal-like breast cancer: a critical review J Clin Oncol 26 2568 2581 18487574 10.1200/JCO.2007.13.1748
16. JS Reis-Filho F Milanezi D Steele K Savage PT Simpson JM Nesland EM Pereira SR Lakhani FC Schmitt 2006 Metaplastic breast carcinomas are basal-like tumours Histopathology 49 10 21 16842242 10.1111/j.1365-2559.2006.02467.x 1:STN:280:DC%2BD28vitFOitA%3D%3D (Pubitemid 43972916)
17. GC Yang HT Yee J Waisman 2003 Metaplastic carcinoma of the breast with rhabdomyosarcomatous element: aspiration cytology with histological, immunohistochemical, and ultrastructural correlations Diagn Cytopathol 28 153 158 12619098 10.1002/dc.10243 (Pubitemid 36307536)
18. DM Abd El-Rehim SE Pinder CE Paish J Bell RW Blamey JF Robertson RI Nicholson IO Ellis 2004 Expression of luminal and basal cytokeratins in human breast carcinoma J Pathol 203 661 671 15141381 10.1002/path.1559 (Pubitemid 38714103)
19. EA Rakha DA El-Rehim C Paish AR Green AH Lee JF Robertson RW Blamey D Macmillan IO Ellis 2006 Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance Eur J Cancer 42 3149 3156 17055256 10.1016/j.ejca.2006.08.015 1:CAS:528:DC%2BD28Xht12rtrzK (Pubitemid 44854512)
20. EA Rakha TC Putti DM Abd El-Rehim C Paish AR Green DG Powe AH Lee JF Robertson IO Ellis 2006 Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation J Pathol 208 495 506 16429394 10.1002/path.1916 1:CAS:528:DC%2BD28XislCqt78%3D (Pubitemid 43329336)
21. LG Fulford JS Reis-Filho K Ryder C Jones CE Gillett A Hanby D Easton SR Lakhani 2007 Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival Breast Cancer Res 9 R4 17217540 10.1186/bcr1636 (Pubitemid 350215157)
22. P Potemski R Kusinska C Watala E Pluciennik AK Bednarek R Kordek 2005 Prognostic relevance of basal cytokeratin expression in operable breast cancer Oncology 69 478 485 16410686 10.1159/000090986
23. F Moinfar 2008 Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes Pathobiology 75 119 131 18544967 10.1159/000123850 1:CAS:528:DC%2BD1cXmvFGksb0%3D (Pubitemid 351820730)
24. J Bartek J Lukas J Bartkova 1999 Perspective: defects in cell cycle control and cancer J Pathol 187 95 99 10341710 10.1002/(SICI)1096-9896(199901) 187:1<95::AID-PATH249>3.0.CO;2-# 1:STN:280:DyaK1M3ntlamtA%3D%3D (Pubitemid 29009839)
25. E Sagiv L Memeo A Karin D Kazanov J Jacob-Hirsch M Mansukhani G Rechavi H Hibshoosh N Arber 2006 CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis Gastroenterology 131 630 639 16890615 10.1053/j.gastro.2006.04.028 1:CAS:528:DC%2BD28XpsFyktrc%3D (Pubitemid 44142443)
26. YH Kim Z Petko S Dzieciatkowski L Lin M Ghiassi S Stain WC Chapman MK Washington J Willis SD Markowitz WM Grady 2006 CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer Genes Chromosomes Cancer 45 781 789 16708352 10.1002/gcc.20341 1:CAS:528:DC%2BD28XmvVGrur8%3D
27. A Karakosta C Golias A Charalabopoulos D Peschos A Batistatou K Charalabopoulos 2005 Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia J Exp Clin Cancer Res 24 505 514 16471312 1:CAS:528:DC%2BD28XhsFaqsb8%3D (Pubitemid 43139542)
28. P Delrio F Fazioli M Di Marzo A Avallone M Elmo B Pecori V Ravo DN Ida P Bianchi F Cremona V De Rosa V Parisi 2005 Combined multistep approach in a locally advanced rectal cancer with sacral invasion: case report Suppl Tumori 4 S7 16437870 1:STN:280:DC%2BD28%2FltlKktw%3D%3D
29. M Narisawa-Saito Y Yoshimatsu S Ohno T Yugawa N Egawa M Fujita S Hirohashi T Kiyono 2008 An in vitro multistep carcinogenesis model for human cervical cancer Cancer Res 68 5699 5705 18632622 10.1158/0008-5472.CAN-07-6862 1:CAS:528:DC%2BD1cXovVCns78%3D
30. F Silva S Carvalho F Milanezi FC Schmitt 2008 Basal-like carcinoma of the breast Acta Med Port 21 373 378 19094813
31. Rakha E, Ellis I, Reis-Filho J. Are triple-negative and basal-like breast cancer synonymous? Clin Cancer Res 2008; 14:618 (author reply pp. 618-619). (Pubitemid 351226133)
32. C Oliveras-Ferraros A Vazquez-Martin E Lopez-Bonet B Martin-Castillo S Del Barco J Brunet JA Menendez 2008 Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer Int J Oncol 33 1165 1176 19020749 1:CAS:528:DC%2BD1cXhsFams7jN